Published on
September 22, 2022
- 12:00 GMT
Alvotech and STADA Increase Access to Adalimumab for Patients in Switzerland with the Launch of Hukyndra®
Hukyndra® increases availability of high-concentration, low-volume, citrate-free presentations of adalimumab Exclusive partnership between Alvotech and STADA in Europe includes Hukyndra® and six biosimilar candidates REYKJAVIK, Iceland and BAD VILBEL, …
Distribution channels:
Companies, Media, Advertising & PR
...
